PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRFX PainReform

Trading 12-11 14:23:00 EST

1.05

+0.08

+8.40%

High1.05	Low0.9409	Vol194.69K
Open0.9628	D1 Closing0.9655	Amplitude11.30%
Mkt Cap4.10M	Tradable Cap3.91M	Total Shares3.92M
T/O198.25K	T/O Rate5.21%	Tradable Shares3.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRFX","market":"US","secType":"STK","nameCN":"PainReform","latestPrice":1.0466,"timestamp":1765480968284,"preClose":0.9655,"halted":0,"volume":194691,"delay":0,"floatShares":3736600,"shares":3915299,"eps":-2.890046,"marketStatus":"Trading","change":0.0811,"latestTime":"12-11 14:23:00 EST","open":0.9628,"high":1.05,"low":0.9409,"amount":198254.3125584,"amplitude":0.112998,"askPrice":1.09,"askSize":1,"bidPrice":1.05,"bidSize":1050,"shortable":3,"etf":0,"ttmEps":-2.890046,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"listingDate":1598932800000,"exchange":"NASDAQ","adjPreClose":0.9655,"preHourTrading":{"tag":"盘前","latestPrice":0.921,"preClose":0.9655,"latestTime":"09:15 EST","volume":267,"amount":248.43400815,"timestamp":1765462535616},"postHourTrading":{"tag":"盘后","latestPrice":0.9303,"preClose":0.9655,"latestTime":"19:09 EST","volume":938,"amount":884.6209,"timestamp":1765411789850},"volumeRatio":0.723563},"requestUrl":"/m/hq/s/PRFX/wiki","defaultTab":"wiki","newsList":[{"id":"2590158705","title":"PainReform Confirms LayerBio Ocular Platform Can Deliver Multiple Drugs in Sustained-Release Form","url":"https://stock-news.laohu8.com/highlight/detail?id=2590158705","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590158705?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:30","pubTimestamp":1765373408,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has announced the completion of a research and development assessment of LayerBio's proprietary drop-less, sustained-release ocular drug-delivery platform. The results confirm that the platform's sustained-release polymer matrix can incorporate a variety of drug entities. This finding supports the platform's long-term potential to improve pharmacological efficiency and simplify postoperative care for cataract patients by reducing or eliminating the need for medicated eye drops. The results were announced by the company and have not been specified as already presented or scheduled to be presented at a future event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to gener","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL1GC1qT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","LU0314104364.USD","NDAQ","BK4588","PRFX","BK4112","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4007","BK4585","SG9999014013.SGD","LU2095319765.USD"],"gpt_icon":0},{"id":"2588141059","title":"BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2588141059","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588141059?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:19","pubTimestamp":1764685168,"startTime":"0","endTime":"0","summary":"BRIEF-Painreform Commences Development For Ocuring-K Phase II TrialDec 2 (Reuters) - PainReform Ltd PRFX.O:PAINREFORM COMMENCES DEVELOPMENT FOR OCURING-K PHASE II TRIAL, LAYERBIO’S DROP-LESS SUSTAINED","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA8LJ8X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2588596050","title":"PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2588596050","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588596050?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:15","pubTimestamp":1764684911,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has announced the commencement of its development plan for OcuRing-K, an innovative, drop-less, sustained-release ocular therapy designed to deliver controlled ketorolac following cataract surgery. The company, in collaboration with LayerBio, is advancing OcuRing-K toward a Phase II clinical trial in the United States. The initial target indication is for post-cataract pain and inflammation, with the goal of providing consistent control with significantly lower drug exposure than traditional eye drops. The research and development efforts are ongoing, and future updates will be provided as the program progresses. No specific scientific research results have been presented yet; the results will be generated and shared following the next stages of clinical development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for infor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL3fn5n6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","PRFX","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","BK4007","NDAQ","BK4588"],"gpt_icon":0},{"id":"2588305963","title":"PainReform Commences Development for Ocuring™-K Phase Ii Trial, Layerbio’s Drop-Less Sustained-Release Ocular Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588305963?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:15","pubTimestamp":1764684900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA8LJ8X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2586940122","title":"PainReform Ltd. Announces December 2025 Shareholders Meeting with Key Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2586940122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586940122?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:54","pubTimestamp":1764107682,"startTime":"0","endTime":"0","summary":"The latest announcement is out from PainReform ( ($PRFX) ). On November 25, 2025, PainReform Ltd. announced its upcoming Annual General Meeting of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-ltd-announces-december-2025-shareholders-meeting-with-key-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-ltd-announces-december-2025-shareholders-meeting-with-key-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2586409152","title":"PainReform Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586409152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586409152?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:16","pubTimestamp":1764105392,"startTime":"0","endTime":"0","summary":"PainReform Ltd. has announced that it will hold its Annual General Meeting of Shareholders on December 30, 2025, at the offices of its attorneys in Tel Aviv, Israel. During the meeting, shareholders will be asked to approve the re-election of Dr. Ehud Geller to the Board of Directors as a Class I director. They will also vote on a proposal to change the company's name from \"PainReform Ltd.\" to \"PRF Ltd.\" and amend the company's articles of association accordingly, subject to regulatory approval. Additionally, shareholders will consider the approval of a grant of options to Asaf Shavit, a member of the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL945FMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2582773653","title":"PainReform’s DeepSolar advances development of AI-driven reporting engine","url":"https://stock-news.laohu8.com/highlight/detail?id=2582773653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582773653?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:10","pubTimestamp":1762956639,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) announced that DeepSolar has advanced the development of its proprietary automated reporting engine, designed to transform how so...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreforms-deepsolar-advances-development-of-ai-driven-reporting-engine-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreforms-deepsolar-advances-development-of-ai-driven-reporting-engine-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX"],"gpt_icon":0},{"id":"2582372511","title":"DeepSolar Advances AI-Driven Reporting Engine for Solar Asset Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2582372511","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582372511?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:00","pubTimestamp":1762956032,"startTime":"0","endTime":"0","summary":"PainReform Ltd.'s solar energy business unit, DeepSolar, is advancing development of its proprietary AI-driven automated reporting engine for solar-asset analysis. The new platform aims to automate data consolidation and reporting, providing tailored, insight-rich performance reports for executive management, investors, and asset owners.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this news brief via GlobeNewswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLk0VS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","LU2095319765.USD","BK4007","BK4585","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","LU2210149790.SGD","PRFX","IE00B3QW5Z07.USD","NDAQ"],"gpt_icon":0},{"id":"2581775944","title":"PainReform’s DeepSolar Advances with NVIDIA Connect and Pilot Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2581775944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581775944?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:17","pubTimestamp":1762352267,"startTime":"0","endTime":"0","summary":"PainReform ( ($PRFX) ) has provided an update. On November 5, 2025, PainReform Ltd. announced that its solar energy unit, DeepSolar, was featured i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreforms-deepsolar-advances-with-nvidia-connect-and-pilot-projects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreforms-deepsolar-advances-with-nvidia-connect-and-pilot-projects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX"],"gpt_icon":0},{"id":"2581778488","title":"BRIEF-PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581778488?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:37","pubTimestamp":1762349873,"startTime":"0","endTime":"0","summary":"BRIEF-PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot ProjectsNov 5 (R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1PDPCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0057025933.USD","LU2413666426.HKD","LU1917777945.USD","LU0077335932.USD","LU0964807845.USD","LU1244550221.USD","LU0348723411.USD","SNVD.UK","NVDY","LU0476273544.USD","LU1804176565.USD","2NVD.UK","LU1633808545.USD","LU0158827781.USD","NVDU","PRFX","LU2023250330.USD","LU0203202063.USD","LU0882574139.USD","LU0203201768.USD","LU1721428933.USD","LU1066051225.USD","NVD","IE00BZ1G4Q59.USD","IE0009356076.USD","LU2452424414.USD","SG9999015986.USD","NVD2.UK","LU2242650005.HKD","LU2168564149.EUR","NVD3.UK","LU0353189680.USD","LU1720051017.SGD","NVDS","LU1699723380.USD","SG9999014542.SGD","LU1923622614.USD","IE00BKPKM429.USD","LU0251132253.USD","NVDD","NVIW.SI","NVDX","LU2506951792.HKD","NVDS.UK","LU1778281490.HKD","LU2125909759.SGD","LU0266013472.USD","3NVD.UK"],"gpt_icon":1},{"id":"2581786637","title":"PainReform’s Deepsolar, Developing “Deepsolar Predict” Within the Nvidia Connect Program, Featured in the Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2581786637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581786637?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:30","pubTimestamp":1762349401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1PDPCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014575.USD","LU2065171311.SGD","IE00B1XK9C88.USD","NVDA","NVIW.SI","NVD2.UK","LU1429558221.USD","NVDY","BK4533","2NVD.UK","IE00BDRTCR15.USD","LU2097344357.USD","LU2413666426.HKD","LU1992135472.HKD","SG9999015952.SGD","LU1066051498.USD","NVDX","LU0048584097.USD","LU1934455863.HKD","NVDL","LU2322448791.USD","LU2087625088.SGD","LU0256863902.USD","LU1815333072.USD","LU2097344431.USD","SNVD.UK","LU1815336760.USD","LU2237438978.USD","NVD3.UK","LU1119994496.HKD","LU1323610961.USD","SGXZ23171101.USD","NVDS.UK","NVD","NVDD","LU1435385759.SGD","LU0310800379.SGD","LU1548497426.USD","LU2361044865.SGD","NVDU","LU2361044949.HKD","LU1821325948.USD","PRFX","3NVD.UK","LU2065171402.SGD","LU0072462426.USD","LU2125909247.SGD","LU2746668974.SGD","NVDS","IE00BJTD4V19.USD"],"gpt_icon":0},{"id":"2572553728","title":"BRIEF-Painreform Provides Business Update For The Six Months Ended June 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2572553728","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572553728?lang=en_us&edition=fundamental","pubTime":"2025-10-01 22:28","pubTimestamp":1759328924,"startTime":"0","endTime":"0","summary":"BRIEF-Painreform Provides Business Update For The Six Months Ended June 30, 2025Oct 1 (Reuters) - PainReform Ltd PRFX.O:PAINREFORM PROVIDES BUSINESS UPDATE FOR THE SIX MONTHS ENDED JUNE 30, 2025Source text: ID:nGNX2RDnkBFurther company coverage: PRFX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA40BKMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2572532708","title":"PainReform Announces H1 2025 Financial Results and Board Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2572532708","media":"TIPRANKS","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572532708?lang=en_us&edition=fundamental","pubTime":"2025-10-01 21:59","pubTimestamp":1759327153,"startTime":"0","endTime":"0","summary":"An update from PainReform ( ($PRFX) ) is now available. On October 1, 2025, PainReform Ltd. announced its financial results for the first half of t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-announces-h1-2025-financial-results-and-board-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-announces-h1-2025-financial-results-and-board-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2572246534","title":"PainReform Ltd. Reports Reduced Net Loss and Maintains Positive Working Capital for First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2572246534","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572246534?lang=en_us&edition=fundamental","pubTime":"2025-10-01 21:28","pubTimestamp":1759325281,"startTime":"0","endTime":"0","summary":"For the six months ended June 30, 2025, general and administrative expenses were $1.9 million, compared to $1.5 million for the six months ended June 30, 2024. The increase was mainly attributable to higher legal costs and share-based compensation expenses. Research and development expenses were $0.3 million for the six months ended June 30, 2025, compared to $11.4 million for the six months ended June 30, 2024. The decrease was primarily due to the completion of the Phase 3 clinical trial evaluating PRF-110 in 2024. Financial income, net, was $52,000 for the six months ended June 30, 2025, compared to $92,000 for the six months ended June 30, 2024. The decrease was primarily due to lower cash balances in 2025. Net loss for the six months ended June 30, 2025, was $2.3 million, compared to $12.8 million for the six months ended June 30, 2024. As of June 30, 2025, cash and cash equivalents  were $3.5 million, and working capital was $1.5 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL43HLqD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","LU2095319765.USD","BK4007","BK4585","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","LU2210149790.SGD","PRFX","IE00B3QW5Z07.USD","NDAQ"],"gpt_icon":0},{"id":"2572534207","title":"Press Release: PainReform Provides Business Update for the Six Months Ended June 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2572534207","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572534207?lang=en_us&edition=fundamental","pubTime":"2025-10-01 21:27","pubTimestamp":1759325220,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Oct. 01, 2025  -- PainReform Ltd. , a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today provided a business update for the six months ended June 30, 2025.-- Completed majority investment in LayerBio, adding OcuRing-K, a. breakthrough dropless cataract therapy targeting a $9B global market. -- Advanced PRF-110 with ongoing R&D following partially positive efficacy. acceptance into NVIDIA Connect Program, and successful completion of a. 92MW pilot with Econergy that advanced into the Company's first. \"At the same time, we are committed to maintaining financial discipline and resource efficiency. Operating expenses declined meaningfully compared to the prior year period, and we significantly reduced our net loss while preserving a solid working capital position. As we pursue growth opportunities, we will continue to balance innovation with careful expense manage","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235303.USD","LU2125909593.SGD","SG9999014575.USD","LU0689472784.USD","LU0820561909.HKD","LU1989764748.USD","NVIW.SI","SEM","LU1791710582.SGD","NVD2.UK","LU0823414478.USD","NVDY","2NVD.UK","IE00BDRTCR15.USD","LU0323591593.USD","SG9999000418.SGD","LU1116320737.USD","BK4543","NVDX","LU0215105999.USD","LU0056508442.USD","LU1791710400.SGD","LU0256863902.USD","IE00B19Z8W00.USD","LU1037948541.HKD","SNVD.UK","LU0198837287.USD","LU0868494708.USD","TM","NVD3.UK","LU1119994496.HKD","LU0256863811.USD","LU0081259029.USD","NVDS.UK","IE00B1BXHZ80.USD","NVD","NVDD","SG9999001424.SGD","03160","LU1934455194.USD","NVDU","LU2403377893.USD","LU2265009873.SGD","PRFX","3NVD.UK","HK0000306701.USD","NVDS","LU2054465674.USD"],"gpt_icon":1},{"id":"2560116753","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2560116753","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560116753?lang=en_us&edition=fundamental","pubTime":"2025-08-20 01:44","pubTimestamp":1755625453,"startTime":"0","endTime":"0","summary":"PainReform  said Tuesday its solar energy unit, DeepSolar, has been accepted into Nvidia's  Connect Program.Shares of PainReform surged roughly 66% as intraday trading volume catapulted to more than 154 million from a daily average of about 169,000.Laser Photonics  shares soared 89% amid heavy trading intraday after the company reported late Monday a wider net loss and a 317% surge in revenue during Q2.Nearly 116.3 million shares traded intraday compared with a daily average of more than 316,000.Plymouth Industrial REIT  said Tuesday it received an unsolicited, non-binding takeover proposal from Sixth Street Partners for $24.10 per share in cash.Shares jumped 49%, with intraday trading volume at over 4.55 million versus a daily average of about 374,000.Price: 4.63, Change: +2.17, Percent Change: +88.01","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999004303.SGD","NVDS","LU0210533765.USD","NVD2.UK","IE00BN29S564.USD","LU1551013425.SGD","LU0353189763.USD","LU2125909593.SGD","LU1935042991.SGD","LU2361044865.SGD","SGXZ51526630.SGD","NVDY","LU0786609619.USD","LU2750360997.AUD","NVIW.SI","SNVD.UK","NVDL","BK4532","LU0175139822.USD","LU2191332357.HKD","NVDA","LU0310799852.SGD","LU1145028129.USD","LU1861127337.USD","LU0061475181.USD","NVDU","LU0048584097.USD","3NVD.UK","IE00BK4W5M84.HKD","LU0109392836.USD","SGXZ23171101.USD","NVD","LU0158827948.USD","NVDS.UK","PLYM","2NVD.UK","LU2491050154.USD","LU0640476718.USD","LU0345769631.USD","LU0029864427.USD","LU0787776722.HKD","LU1988902786.USD","NVD3.UK","NVDX","PRFX","LASE","LU2125154778.USD","LU0708994859.HKD","NVDD","IE00BMPRXR70.SGD"],"gpt_icon":0},{"id":"2560421199","title":"DeepSolar, a Subsidiary of PainReform Ltd., Joins NVIDIA Connect Program to Enhance AI-Driven Solar Forecasting","url":"https://stock-news.laohu8.com/highlight/detail?id=2560421199","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560421199?lang=en_us&edition=fundamental","pubTime":"2025-08-19 20:30","pubTimestamp":1755606639,"startTime":"0","endTime":"0","summary":"PainReform Ltd.'s subsidiary, DeepSolar, has gained acceptance into the prestigious NVIDIA Connect Program. DeepSolar, a business unit focused on next-generation AI-driven solar analytics, aims to enhance solar forecasting accuracy by up to 50% and optimize energy asset performance. DeepSolar's software platform has already shown the capability to improve energy production and reduce operational and maintenance costs by up to 30%. The acceptance into NVIDIA's program provides them with access to advanced AI tools and resources, strengthening their position as a key player in performance-driven solar asset management. This development supports broader sustainability goals by increasing the reliability and flexibility of renewable power on the grid, aligning with regulatory trends and investor preferences for climate-resilient energy systems.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL6f8XkW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","NVDA","PRFX"],"gpt_icon":1},{"id":"2560199296","title":"PainReform/Deepsolar Accepted Into Nvidia Connect Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2560199296","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560199296?lang=en_us&edition=fundamental","pubTime":"2025-08-19 20:30","pubTimestamp":1755606601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nTUA9X6J75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","LU2543165471.USD","NVD3.UK","NVD","SG9999014542.SGD","SG9999015952.SGD","BK4581","NVDD","LU0158827948.USD","LU1989764748.USD","LU2552382215.SGD","BK4579","NVDL","LU0965509283.SGD","SG9999002224.SGD","SGXZ23171101.USD","NVD2.UK","PRFX","LU2092937148.SGD","BK4608","LU1935043536.SGD","LU0472753341.HKD","NVDS","LU1989772923.USD","LU1989764664.SGD","IE00BYXW3230.USD","2NVD.UK","NVDU","NVDX","BK4529","NVDA","LU2264538146.SGD","LU2413666426.HKD","LU0203201768.USD","NVIW.SI","LU2168564065.EUR","LU1868837300.USD","NVDS.UK","LU0345768740.USD","LU1934455863.HKD","IE00BDRTCR15.USD","LU2487616109.SGD","BK4534","3NVD.UK","LU0006306889.USD","SNVD.UK","LU1642822529.SGD","LU0823421416.USD","NVDY","LU2322448957.HKD"],"gpt_icon":0},{"id":"2559617981","title":"PainReform Ltd. Announces New Clinical Trial for Breakthrough OcuRing™-K Technology Targeting Post-Cataract Surgery Pain Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2559617981","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559617981?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:19","pubTimestamp":1755116394,"startTime":"0","endTime":"0","summary":"PainReform Ltd. Announces New Clinical Trial for Breakthrough OcuRing-K Technology Targeting Post-Cataract Surgery Pain Management. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PainReform Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL1BJsdJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2559602320","title":"PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System","url":"https://stock-news.laohu8.com/highlight/detail?id=2559602320","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559602320?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:30","pubTimestamp":1755088200,"startTime":"0","endTime":"0","summary":"Acquisition of Majority Equity Interest in LayerBio and its OcuRing-K Technology Targets Growing Demand for ‘Dropless’ Solutions in Ophthalmic SurgeryTEL AVIV, Israel, Aug.  13, 2025  (GLOBE NEWSWIRE)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132576/0/en/PainReform-Ltd-Completes-Strategic-Investment-in-LayerBio-to-Enter-9B-Global-Cataract-Surgery-Market-with-Breakthrough-Non-Opiate-Non-Steroidal-Postoperative-NSAID-Drug-Delivery-Sy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.painreform.com","stockEarnings":[{"period":"1week","weight":0.0271},{"period":"1month","weight":0.0342},{"period":"3month","weight":-0.3295},{"period":"6month","weight":-0.4809},{"period":"1year","weight":-0.6782},{"period":"ytd","weight":-0.7122}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058575},{"month":2,"riseRate":0.6,"avgChangeRate":0.112661},{"month":3,"riseRate":0.4,"avgChangeRate":-0.068689},{"month":4,"riseRate":0.2,"avgChangeRate":-0.216174},{"month":5,"riseRate":0,"avgChangeRate":-0.142442},{"month":6,"riseRate":0.4,"avgChangeRate":-0.0782},{"month":7,"riseRate":0.4,"avgChangeRate":-0.022654},{"month":8,"riseRate":0.4,"avgChangeRate":-0.15911},{"month":9,"riseRate":0.2,"avgChangeRate":-0.17317},{"month":10,"riseRate":0,"avgChangeRate":-0.160968},{"month":11,"riseRate":0.5,"avgChangeRate":-0.020834},{"month":12,"riseRate":0.5,"avgChangeRate":-0.016055}],"exchange":"NASDAQ","name":"PainReform","nameEN":"PainReform"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PainReform(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PainReform,PRFX,PainReform股票,PainReform股票老虎,PainReform股票老虎国际,PainReform行情,PainReform股票行情,PainReform股价,PainReform股市,PainReform股票价格,PainReform股票交易,PainReform股票购买,PainReform股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PainReform(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction